Keller and Heckman offers global food and drug services to its clients. Our comprehensive and extensive food and drug practice is one of the largest in the world. We promote, protect, and defend products made by the spectrum of industries regulated by the U.S. Food and Drug Administration (FDA), the European Commission and Member States authorities in the European Union (EU) and similar authorities throughout the world. The products we help get to market include foods, pharmaceuticals, medical devices, veterinary products, dietary supplements, and cosmetics. In addition, we have a very comprehensive practice in the regulation of packaging materials for food, drugs, and cosmetics and other food-contact articles. We represent clients in addressing all issues relating to these products, including the suitability of their composition, inspection of manufacturing facilities, labeling and advertising, recall procedures, quality assurance programs, and appropriate responses to consumer complaints and tampering incidents. We also vigorously defend our clients when threatened by unwarranted action by competitors or regulatory authorities. We also have substantial experience conducting "due diligence" audits of marketed products, labeling, advertising claims, and manufacturing operations, both for the clients' internal control purposes and as part of product line or corporate acquisitions.
More Legal and Business Bylines From Food and Drug Law at Keller and Heckman
- Dietary Ingredient Notifications: Extension to Vinpocetine Comment Period Requested - (Posted On Thursday, October 13, 2016)
- WHO Report Supports Effectiveness of Sugary Food and Drink Taxes - (Posted On Wednesday, October 12, 2016)
- Tracking Compliance Dates for FDA Nutrition Initiatives - (Posted On Tuesday, October 11, 2016)
- EU Tackles Acrylamide - (Posted On Friday, October 07, 2016)
- FDA Issues Updated Manufactured Food Regulatory Program Standards - (Posted On Thursday, October 06, 2016)
- WHO Chief Calls on Consumers to Choose “Antibiotic-Free” Meat - (Posted On Wednesday, October 05, 2016)
- Food Industry Generally Supports Extending POS Signage for Calif. Prop 65 BPA Warnings - (Posted On Tuesday, October 04, 2016)
- Food Safety and Inspection Service Requests Comments on Labeling Guidance for Animal Raising Claims - (Posted On Monday, October 03, 2016)
- New Settlement Terms for California’s Prop 65 Become Effective Oct. 1 - (Posted On Friday, September 30, 2016)
- Fruit Labeling Accuracy Act of 2016 Would Prohibit Added Sugars Labeling for Naturally Tart Fruits - (Posted On Thursday, September 29, 2016)
Keller and Heckman’s Food and Drug Law Practice Group is a Go-To Thought Leader for 2021 for its coverage of Food Labeling Class Action Lawsuits and Regulatory news. The group regularly provides interesting, comprehensive news on topics ranging from class-action lawsuits involving Snack Foods lacking real Wasabi and Canned Green Beans inaccurately claiming to be preservative-free, to proposed federal legislation regulating CBD in food products. NLR readers appreciate the group’s efforts to break down lawsuits and pending legislation impacting the nation's food supply.
The National Law Review Recognizes Keller and Heckman’s Food and Drug Law Practice Group as Go-To Thought Leaders for the firm’s contributions on FDA Regulations and guidelines. Keller and Heckman’s expansive FDA coverage included: proposed rules expanding food traceability and record-keeping requirements, new guidance for animal food additives, a final rule concerning gluten-free food labeling, and approval of a new peanut allergy drug. Addressing the COVID-19 crisis, Keller & Heckman provided news about warnings required by the FDA for Purell and other actions about hand sanitizer and additional Coronavirus prevention and cure claims, the FDA’s and OSHA’s employee health and food safety checklist(s) and COVID-19 best practices for retail and restaurants and COVID-19 Guidance to U.S. food exporters. The firm’s most frequent FDA / Food and Drug Law attorney contributors to the NLR include Azim Chowdhury, Sheila A. Millar, Evangelia Pelonis, Natalie Rainer and LieAnn Van-Tull.